Abstract
This chapter discusses how companies can apply compendial procedures to monitor the stability of their product through product expiry. When companies are able to employ compendial procedures for stability monitoring purposes they may save time and money because they will not need to validate new procedures. In addition, the drug approval process may be quickened by referencing methods already approved and familiar to the regulatory authorities.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
U.S. Pharmacopeial Convention (USP) (2008) USP 31-NF 26: USP general notices and requirements for references to the USP and NF. USP, Rockville, MD.
Federal Food, Drug, and Cosmetic Act, 21 USC § 501(b).
USP (2008) USP 31-NF 26: USP general notices and requirements, section: tests and assays, subsection: procedures. USP, Rockville, MD.
Schniepp, SJ, (2006) Understanding the united states pharmacopeia and the national formulary: demystifying the standards-setting process. Davis Healthcare International Publishing, Moore, OK.
ICH Q6A, Specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances.
ICH Q6B, Specifications: test procedures and acceptance criteria for biotechnological/biological products.
USP website: http://www.usp.org/USPNF/submitMonograph/subGuide.html.
21 CFR 211.194(a) and 211.194 (a)(2).
ICH Q2(R1), Validation of analytical procedures: text and methodology.
ICH Q3A, Impurities in new drug substances.
ICH Q3B, Impurities in new drug products.
ICH Q3C, Impurities: guidelines for residual solvents.
ICH Q1A(R2), Stability testing of new drug substances and products.
ICH Q1C, Stability testing for new dosage forms.
ICH Q1E, Evaluation for stability data.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schniepp, S. (2009). Overview of USP-NF Requirements for Stability Purposes. In: Huynh-Ba, K. (eds) Handbook of Stability Testing in Pharmaceutical Development. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85627-8_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-85627-8_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-85626-1
Online ISBN: 978-0-387-85627-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)